La Jolla, California -- OxyHeal Health Group® (OxyHeal®) announced today that one of its group companies has been awarded a contract through its representative in the Kingdom of Saudi Arabia, Al JEEL Medical Company (al JEEL). The contract includes the design, manufacture, and installation of a rectangular multiplace hyperbaric chamber system at The Autism Research and Treatment center (ART Center) the King Khaled University Hospital, at King Saud University in Riyadh, Saudi Arabia. King Khaled University Hospital is associated with King Saud University, the oldest and most prestigious university in Riyadh. Under this contract, training of the hospital staff will be accomplished through OxyHeal’s premier educational entity, the OxyHeal® University, Inc. All technical and manufacturing work on this project will be contracted to OxyHeal® Medical Systems, Inc. (OMS), a member company of the OxyHeal Health Group®. Al JEEL will provide facility modification and construction, on-site installation support, after-sales technical support, and other direct services to the hospital.

The acquisition of the OxyHeal® 5000 Series rectangular multiplace hyperbaric chamber will be part of an on-going Autism research program undertaken by King Saud University. In this application the chamber will be used in both traditional HBO treatments and as part of the Autism research program at The Autism Research and Treatment center (ART Center). The new chamber system expands the hyperbaric medical treatment capabilities provided by the staff of the hospital and gives them unparalleled abilities to conduct both clinical treatments and research. The state-of-the-art OxyHeal® 5000 will be the largest and first rectangular hyperbaric chamber system to be placed into service in both the Kingdom of Saudi Arabia and in the Gulf region, as well as the entire Middle East and the Asian continent.

The OxyHeal® 5000 is capable of performing simultaneous treatments on up to eight (8) subjects at pressures up to six atmospheres absolute (6-ATA). In particular the system is suited for the treatment of decompression diving emergencies (e.g. commercial, professional, and SCUBA divers) in addition to its potential use to perform hyperbaric and diving research. The main compartment features two large 30-inch (76cm) diameter viewports and an over-sized 48-inch (1.2 meter) wide patient walk-in door that can easily accommodate gurney bound patients. In addition, the chamber will feature OxyHeal®’s Aquatic Series Wall Mural™ (Series No. 2) which presents a pleasing chamber exterior which helps the chamber system blend into the clinical environment. This unique space-age chamber finishing system, pioneered by OxyHeal®, combines with the chamber’s rectangular configuration with stunning aquatic visual images. This enhances comfort and improves compliance by providing a familiar and comforting environment to the patient and brings the provision of hyperbaric medicine treatments into the 21st century.

“I am very pleased to announce the news that OxyHeal® has been selected to provide our OxyHeal® 5000 Series rectangular multiplace hyperbaric chamber system to the King Khaled University Hospital,” said W. T. ‘Ted’ Gurneé, the President & CEO of the OxyHeal Health Group® of companies. “Once again, OxyHeal® has emerged as the original equipment of manufacturer (OEM) of choice after a very rigorous international selection process and in direct competition against other recognized leaders in hyperbaric chamber system design and manufacture. Al JEEL worked tirelessly with the customer to demonstrate the benefits and superiority of our rectangular chamber system over the competition and we look forward to working with them on future projects within the Kingdom and in the Gulf region.”

About OxyHeal Health Group®
The OxyHeal® Health Group, Inc. is an integrated services firm engaged in the contract management of Wound Healing and Hyperbaric Medicine programs. OxyHeal® Medical Systems, Inc. (OMS) is a vertically integrated designer and manufacturer of hyperbaric and hypobaric chamber systems. OMS is certified under ASME, PVHO and ISO quality standards, as well as to the European and Canadian quality standards. OMS is also a certified manufacturing company by the National Board, is a registered medical device manufacturer with the U.S. FDA, and holds a Class III Medical Device license from Health Canada as a medical device manufacturer. OMS maintains an ISO 13485:2003 Quality Management System certified by DQS GmbH. OxyHeal® University, Inc. is fully engaged in a variety of hyperbaric oxygen clinical operations, hyperbaric equipment, and systems training; and the support of hyperbaric oxygen related research. In summary, OxyHeal® is certified to manufactures pressure vessels to all major world-wide standards and to train its customer in the use of those systems.

OxyHeal® is very proud of its long history in conducting hyperbaric research. Of particular note is that OxyHeal® is participating in the first Investigational New Drug (IND) trial, utilizing Hyperbaric Oxygen as the drug, under FDA supervision for the treatment of Traumatic Brain Injury (TBI) and Post Traumatic Stress Syndrome (PTSS).

OxyHeal® maintains a comprehensive history of unique qualifications and experience in the design and manufacture of large multiplace hyperbaric chamber systems. Its rich history encompasses over 40 years of experience that also includes clinical operations and research utilizing hyperbaric oxygen therapy (HBOT); providing unique hyperbaric professional training for health care, maintenance professionals, and the military; and whole of life costs support for each of the systems it has delivered. For more information, please visit http://www.oxyheal.com.

Contact:
W.T. Gurneé, President and CEO
Tel: 619-336-2022
Fax: 619-336-2017
Web: www.oxyheal.com